Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02092909 |
| Title | Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia (8400-401) |
| Acronym | 8400-401 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Idera Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cancer Centers of Excellence | Fayetteville | Arkansas | 72758 | United States | Details | |
| UCLA | Los Angeles | California | 90404 | United States | Details | |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | United States | Details | |
| Emory Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
| Horizon BioAdvance | Lafayette | Indiana | 47905 | United States | Details | |
| Mayo Clinic | Rochester | Minnesota | 55902 | United States | Details | |
| Hackensack University | Hackensack | New Jersey | 07601 | United States | Details | |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details |